Mizuho Financial Group, Inc., together with its subsidiaries, engages in banking, trust, securities, and other businesses related to financial services in Japan, the Americas, Europe, Asia/Oceania, and internationally. It operates through Retail & Business Banking Company, Corporate & Institutional Company, Global Corporate Company, Global Markets Company, Asset Management Company, and Others segments. The company provides deposit products; syndicated, housing, and card loans; business matching services; and advisory services related to overseas expansions, and mergers and acquisitions-related services. It also offers consulting services, including asset management and asset succession; payroll services; and sells lottery tickets issued by prefectures and ordinance-designated cities. In addition, it offers fund management, underwriting of equity and bonds, risk hedging products, etc. for corporate customers; solutions based on capital management, business strategy, and financial strategy; real estate services; advisory services and solutions, such as advice on proposals on various investment products to financial institutions; and financial services that include funding support and public bonds underwriting. Further, the company offers corporate finance and transaction banking srvices; sales and trading services; investment products; pension funds; and ALM and investment services, including stable capital raising and balance sheet management, as well as management of fixed income, equity, and other securities portfolios. Additionally, the company provides online banking, cash management solutions, currency transaction, trade finance, custody, yen correspondence settlement, and research and consulting services; trust, securitization and structured finance, and stock transfers; and private banking and information technology-related services. Mizuho Financial Group, Inc. was founded in 2000 and is headquartered in Tokyo, Japan.

Mizuho Financial Group демонстрирует значительно низкие мультипликаторы, такие как P/E, P/S и P/B, которые находятся на уровне 2.06, 0.26 и 0.11 соответственно, что указывает на возможную недооцененность. Однако, их эффективность, выраженная в ROE и ROA, значительно ниже медиан отрасли, что является негативным фактором. Долговая нагрузка компании также вызывает беспокойство — коэффициент долга к капиталу превышает медиану отрасли на 158.7%. Тем не менее, общие финансовые показатели, такие как выручка и чистая прибыль, показывают значительный рост, что положительно сказывается на оценке. Дивиденды, хотя и сниженные в последние годы, все еще остаются на уровне 1.39%. В целом, несмотря на некоторые сильные стороны, такие как высокие показатели выручки и чистой прибыли, низкие мультипликаторы и ухудшающаяся эффективность ставят под сомнение текущую целевую цену акций, что приводит к необходимой корректировке прогноза.

Mizuho Financial Group, Inc. Sponosred

Key Points
Hot inflation data sent speculative stocks like Rigetti tumbling as investors brace for the Fed to delay rate cuts.
A price target cut on rival D-Wave Quantum added pressure across the quantum computing sector.
Rigetti's current valuation prices in enormous success that remains far from guaranteed.
Shares of quantum computing company Rigetti Computing (NASDAQ: RGTI) tumbled Friday, finishing the day down 6.6%.
A one-two punch hit the stock: a hotter-than-expected inflation report and a Wall Street price cut on shares of quantum computing peer, D-Wave Quantum.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Rigetti stock is sliding on troubling economic data
Friday's producer price index (PPI) showed core wholesale prices surging 0.8% in January -- nearly triple the 0.3% economists had forecast. The hot inflation numbers likely mean the Federal Reserve will hold off on any rate cuts for longer than expected, and that is not good news for more speculative stocks like Rigetti's.
When interest rates stay elevated, investors are less willing to pay a premium for future profits, especially when those profits are as uncertain as Rigetti's.
D-Wave Quantum stock gets a price cut
On top of that, analysts at Mizuho slashed its price target on D-Wave stock from $46 to $40 on Friday. The company is a close rival of Rigetti, and at this point, investors tend to tie the fates of all of the quantum pure-plays together.
Is Rigetti stock worth buying on the dip?
Quantum computing may well transform entire industries someday. But I think "someday" has a good chance of being much further off than quantum bulls would hope. Rigetti's valuation is still pricing in enormous success that is far from guaranteed. I wouldn't invest until Rigetti's valuation is more in line with reality.
Should you buy stock in Rigetti Computing right now?
Before you buy stock in Rigetti Computing, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Rigetti Computing wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $456,188!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,133,413!*
Now, it’s worth noting Stock Advisor’s total average return is 916% — a market-crushing outperformance compared to 194% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of February 27, 2026.
Johnny Rice has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Why Rigetti Computing Stock Slumped on Friday

NVIDIA Corporation’s NVDA shares declined 2.9% on reports that its much-anticipated $100 billion investment in OpenAI had become uncertain or was being scaled back.
Shares of Mizuho Financial Group, Inc. MFG rose 2.4% after the company reported third-quarter fiscal 2026 earnings of 16 cents per share, beating the Zacks Consensus Estimate of 14 cents.
Shares of The Walt Disney Company DIS plunged 7.4% over concerns that international visitations to its theme parks in the United States had declined.
Aptiv PLC’s APTV shares gained 2.9% after the company reported fourth-quarter 2025 revenues of $5.15 billion, beating the Zacks Consensus Estimate of $5.07 billion.
Radical New Technology Could Hand Investors Huge Gains
Quantum Computing is the next technological revolution, and it could be even more advanced than AI.
While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.
Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.
Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.
See Top Quantum Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
NVIDIA Corporation (NVDA) : Free Stock Analysis Report
Aptiv PLC (APTV) : Free Stock Analysis Report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Company News for Feb 3, 2026

Key Points
Broadcom stock is bouncing back today after falling lower on Thursday.
A Mizuho analyst raised the price target on Broadcom stock.
Shares of Broadcom are trading at a premium to their historical valuations.
After ending yesterday's market session about 3% lower from where they were at the close of trading on Wednesday, Broadcom (NASDAQ: AVGO) stock is heading higher today, poised to end the week on a positive note.
As of 2:28 p.m. ET, shares of the semiconductor specialist are up 4.1%.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
One analyst believes that Broadcom stock has plenty of room to run in 2026
Maintain an outperform rating, Vijay Rakesh, an analyst at Mizuho, lifted the price target on Broadcom stock to $480 from $450.
According to theFly.com, Rakesh based his more optimistic outlook on Broadcom stock after the firm revisited its price targets on semiconductor stocks, believing that many of them have "attractive valuations." Providing an even more ringing endorsement of Broadcom stock, Mizuho named Broadcom as one of its top semiconductor picks for 2026.
Is it too late now to pick up shares of Broadcom?
While Rakesh sees significant upside to Broadcom stock, investors should hardly take this data point in isolation. Those considering a position in the semiconductor stock should also recognize that shares are trading at a premium to their historical valuation. Currently, Broadcom stock is changing hands at a price-to-earnings ratio of 69.7, a lofty valuation considering its five-year average trailing P/E of 40.2. For those committed to a Broadcom investment, the stock's rich valuation may be less of a concern. Still, those interested in a semiconductor stock that offers a value opportunity will want to look elsewhere.
Should you buy stock in Broadcom right now?
Before you buy stock in Broadcom, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Broadcom wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $488,222!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,134,333!*
Now, it’s worth noting Stock Advisor’s total average return is 969% — a market-crushing outperformance compared to 196% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of January 9, 2026.
Scott Levine has no position in any of the stocks mentioned. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Why Broadcom Stock Is Rising Today

Key Points
It delivered a blowout third quarter.
The fuel cell developer also posted its fourth straight all-time high revenue figure.
Stock market players were more than energized about Bloom Energy (NYSE: BE) over the past several trading days. Thanks to a well-received quarterly earnings report, a clutch of fresh analyst price target hikes, and some news on the financing front, the company's shares were on the rise.
As of early Friday morning, according to data compiled by S&P Global Market Intelligence, they had gained nearly 16% week to date.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Four in a row
Bloom, a developer of cutting-edge fuel cell products, posted its third-quarter results on Tuesday. The company didn't hesitate to say that with its $519 million on the top line -- 57% higher year over year, by the way -- it notched its fourth straight all-time high revenue figure.
Net income not according to generally accepted accounting principles (GAAP) also saw a supercharged leap, rising by 60% to exceed $34 million.
On average, analysts were collectively modeling only $428 million on the top line, and $0.10 per share for non-GAAP (adjusted) net income.
Inspired by that over-performance, analysts tracking Bloom wasted little time making bullish adjustments to their takes. Among the Bloom-watchers raising their price targets were Morgan Stanley, Mizuho, and HSBC.
A $1.75 billion move
Bloom also had news to report in the financing sphere. On Thursday, it divulged that it intended to float a $1.75 billion aggregate principal amount of convertible senior notes bearing interest of 0% and maturing on Nov. 15, 2030. The notes will be convertible into its class A stock, cash, or a mix of both, although it hasn't published any details yet.
Bloom said it would use its proceeds from the issue for "general corporate purposes," which include the support of research and development and its manufacturing efforts.
Should you invest $1,000 in Bloom Energy right now?
Before you buy stock in Bloom Energy, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Bloom Energy wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $593,442!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,269,127!*
Now, it’s worth noting Stock Advisor’s total average return is 1,071% — a market-crushing outperformance compared to 196% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of October 27, 2025
HSBC Holdings is an advertising partner of Motley Fool Money. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool recommends HSBC Holdings. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Why This Was a Good Week to Plow Into Bloom Energy Stock

The Avantis Responsible International Equity ETF is seeing unusually high volume in afternoon trading Monday, with over 336,000 shares traded versus three month average volume of about 34,000. Shares of AVSD were up about 0.9% on the day.
Components of that ETF with the highest volume on Monday were Nokia, trading down about 0.7% with over 20.9 million shares changing hands so far this session, and Grab Holdings, up about 0.5% on volume of over 16.7 million shares. Mizuho Financial Group is the component faring the best Monday, up by about 4.1% on the day, while Genmab is lagging other components of the Avantis Responsible International Equity ETF, trading lower by about 7.6%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Monday's ETF with Unusual Volume: AVSD

Key Points
Cloud and AI are Alibaba's growth engines.
Its valuation remains attractive even after the rally.
Competition, macro uncertainty, and regulatory risks remain, but early signs of strategy execution and sentiment shifts suggest the recovery may not be over.
Alibaba Group (NYSE: BABA) has tested investors' patience over the past few years. Regulators cracked down, China's consumer spending slowed, and rivals like Pinduoduo and Meituan intensified competition. The company went from China's undisputed tech champion to a stock that many investors abandoned.
In 2025, the story shifted. Alibaba's stock surged nearly 87% in the last 12 months (as of this writing on September 17), crushing the Hang Seng Index and even outpacing the Nasdaq Composite. With such a sharp rebound, investors now face the question: Should they take profits, or hold on for more upside?
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
What fueled the rally?
The recent rally isn't just sentiment-driven -- Alibaba has started delivering tangible progress in areas investors care about.
In its June 2025 quarter (fiscal Q1 2026), the company reported revenue of RMB 248 billion ($34.6 billion), up 10% year over year (on a like-for-like basis), marking a return to double-digit growth after a stretch of stagnation. More importantly, its cloud business has become the standout performer. Alibaba Cloud revenue surged 26% to RMB 33.4 billion ($4.7 billion), and management disclosed that AI-related revenue grew at triple-digit rates for the eighth consecutive quarter.
That shift is critical because cloud and AI are where the growth is, compared to Alibaba's traditional e-commerce business. With its large language model, Tongyi Qianwen, already integrated across enterprise and consumer applications, Alibaba is positioning itself not just as an e-commerce leader but as an AI platform provider.
Meanwhile, Alibaba has also leaned into growth areas like quick commerce to defend engagement against Meituan and Pinduoduo. While costly in the short term, these moves show management is willing to play offense again rather than simply cutting costs. So far, the outcome has been solid, with e-commerce growing at 10% year over year in the latest quarter.
Together, stronger results, a credible AI story, and signs of renewed strategy execution have fueled the stock's rebound.
The risk of selling too soon
After a near doubling in share price, it's tempting to lock in gains. But selling stock now can mean missing out on the next leg higher.
Alibaba's stock remains far below its peak valuation. At a price-to-sales ratio of just 2.8, shares trade at a fraction of their 2020 multiple of around 7-9 times. Even after the rally, Alibaba is valued more like a retailer than a dominant technology platform with multiple growth levers.
Investor sentiment is also just beginning to shift. In recent weeks, analysts at Mizuho, Bernstein, and Citi raised their price targets or reiterated bullish ratings, citing cloud momentum and AI adoption as underappreciated catalysts. If earnings momentum continues, more institutional investors may return to the stock, driving a potential rerating.
In short, the fundamentals don't suggest Alibaba has already "topped out." Instead, the recovery could be in its early stages if execution holds up.
Alibaba has plenty of work remaining to do
Still, the rally is not entirely risk-free. Alibaba still faces fierce competition in its core e-commerce business from Pinduoduo's low-price strategy and Meituan's dominance in local services. Profitability has also come under pressure from its heavy investments in quick commerce, which weighed on earnings last quarter despite healthy revenue growth. For perspective, non-GAAP net income fell 18% in the latest quarter despite improving revenue.
Geopolitics remains another overhang. U.S.-China tensions around technology exports could complicate Alibaba's cloud and AI ambitions, though the company is hedging this risk by developing its own domestic AI chips.
These factors mean investors should expect volatility ahead, even if the long-term trajectory improves.
What it means for investors
Alibaba's massive rally in 2025 is impressive, but context matters. The stock has rebounded from depressed levels and still trades at attractive valuations. The company's cloud and AI growth show genuine signs of transformation, and early sentiment shifts hint that institutional investors are beginning to take notice.
At the same time, Alibaba isn't out of the woods yet. Competition, macro uncertainty, and regulatory risks remain part of the story.
That's why the best framing may be this: Alibaba is moving from being a "broken" stock to one with optionality again. In other words, the recovery may have more room to run, provided Alibaba executes on its cloud, AI, and commerce strategies in the coming quarters.
For long-term investors, that makes holding -- rather than selling into the rally -- a reasonable approach.
Should you invest $1,000 in Alibaba Group right now?
Before you buy stock in Alibaba Group, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Alibaba Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $651,345!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,080,327!*
Now, it’s worth noting Stock Advisor’s total average return is 1,058% — a market-crushing outperformance compared to 189% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of September 15, 2025
Citigroup is an advertising partner of Motley Fool Money. Lawrence Nga has positions in Alibaba Group and PDD Holdings. The Motley Fool recommends Alibaba Group. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Alibaba Stock Is Up 87%. Time to Sell?

The NASDAQ 100 Pre-Market Indicator is down -34.79 to 22,745.81. The total Pre-Market volume is currently 211,217,439 shares traded.
The following are the most active stocks for the pre-market session:
BIT Mining Limited (BTCM) is +1.11 at $5.07, with 12,627,830 shares traded.
Direxion Daily TSLA Bull 2X Shares (TSLL) is +0.31 at $11.59, with 9,576,771 shares traded. This represents a 84.26% increase from its 52 Week Low.
Above Food Ingredients Inc. (ABVE) is -0.691 at $2.94, with 5,256,779 shares traded., following a 52-week high recorded in prior regular session.
NIO Inc. (NIO) is +0.2 at $4.10, with 5,140,442 shares traded. NIO's current last sale is 102.5% of the target price of $4.
iShares Bitcoin Trust ETF (IBIT) is +1.98 at $69.19, with 4,973,854 shares traded., following a 52-week high recorded in prior regular session.
ProShares UltraPro Short QQQ (SQQQ) is +0.14 at $19.51, with 4,047,610 shares traded. This represents a 2.74% increase from its 52 Week Low.
NVIDIA Corporation (NVDA) is +0.3697 at $165.29, with 3,440,030 shares traded., following a 52-week high recorded in prior regular session.
ProShares UltraPro QQQ (TQQQ) is -0.4998 at $83.22, with 2,500,482 shares traded. This represents a 137.77% increase from its 52 Week Low.
BigBear.ai, Inc. (BBAI) is -0.12 at $6.32, with 2,199,457 shares traded. BBAI's current last sale is 126.4% of the target price of $5.
Sequans Communications S.A. (SQNS) is +0.75 at $5.25, with 2,191,181 shares traded., following a 52-week high recorded in prior regular session.
Mizuho Financial Group, Inc. (MFG) is unchanged at $5.50, with 1,677,325 shares traded. As reported by Zacks, the current mean recommendation for MFG is in the "buy range".
Oscar Health, Inc. (OSCR) is unchanged at $14.38, with 1,279,800 shares traded. OSCR's current last sale is 89.88% of the target price of $16.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Pre-Market Most Active for Jul 14, 2025 : BTCM, TSLL, ABVE, NIO, IBIT, SQQQ, NVDA, TQQQ, BBAI, SQNS, MFG, OSCR

A badly received quarterly earnings report was the major news item exerting gravity on Chewy (NYSE: CHWY) stock over the past few days. As a result, according to data compiled by S&P Global Market Intelligence, the company's share price had slumped by almost 15% week-to-date as of Thursday evening.
Investors didn't like the latest milk bone
That sell-off happened even though Chewy actually topped analyst estimates for revenue and profitability, albeit not by vast amounts.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
In its first quarter, the company managed to grow its net sales by more than 8% year over year to $3.1 billion, while its non-GAAP (adjusted) net income improved at a slightly higher rate to just under $149 million ($0.35 per share). Analysts had collectively been modeling a bit below $3.1 billion on the top line and $0.32 per share for adjusted profitability.
While those aren't bad numbers at first glance, Chewy is an expensive stock to own; even after the post-earnings sell-off it was trading at a rich forward P/E of almost 36. For more than a few investors, that's awfully pricey for a company posting single-digit percentage improvements, and at thin profit margins to boot.
Tepid reactions
Meanwhile, as analysts tracking a stock often do, several pundits following Chewy adjusted their takes on the stock. Most of these adjusters raised their price targets, but there were several less bullish updates, too. One was published by Mizuho's David Bellinger, who now feels Chewy is worth $44 per share, down from his previous $47. He maintained his neutral recommendation on the stock.
It's hard to ignore how pricey this stock is at the moment, and to some degree that's a shame. Chewy has been posting good results from its Autoship program lately, a feature that still has plenty of potential to boost valuable recurring revenue. I'm not necessarily hot on this stock, but there might be some upside to it if it can post more convincing quarterly earnings beats.
Should you invest $1,000 in Chewy right now?
Before you buy stock in Chewy, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Chewy wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $655,255!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $888,780!*
Now, it’s worth noting Stock Advisor’s total average return is 999% — a market-crushing outperformance compared to 174% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of June 9, 2025
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Chewy. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

Why Chewy Stock Was Diving This Week

Saint Louis, Missouri-based Emerson Electric Co. (EMR) is a technology and software company that provides various solutions. With a market cap of $61.1 billion, the company offers control systems, sensors, and valves, as well as electrical infrastructure and tools for industrial, commercial, and consumer markets worldwide.
Shares of this automation giant have underperformed the broader market over the past year. EMR has gained 1.7% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 10.2%. In 2025, EMR stock is down 12.6%, compared to SPX’s 3.9% decline on a YTD basis.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
Narrowing the focus, EMR’s underperformance looks less pronounced compared to the Gabelli Automation ETF (GAST). The exchange-traded fund has gained about 2.2% over the past year. Moreover, the ETF’s 4.3% losses on a YTD basis outshine the stock’s double-digit dip over the same time frame.
On Feb. 5, EMR shares closed down more than 2% after reporting its Q1 results. Its adjusted EPS of $1.38 topped Wall Street expectations of $1.28. The company’s revenue was $4.18 billion, falling short of Wall Street forecasts of $4.21 billion. The company expects full-year adjusted EPS to be between $5.85 and $6.05.
For the current fiscal year, ending in September, analysts expect EMR’s EPS to grow 8.2% to $5.94 on a diluted basis. The company’s earnings surprise history is impressive. It beat the consensus estimate in each of the last four quarters.
Among the 24 analysts covering EMR stock, the consensus is a “Moderate Buy.” That’s based on 17 “Strong Buy” ratings, one “Moderate Buy,” four “Holds,” one “Moderate Sell,” and one “Strong Sell.”
This configuration is more bullish than two months ago, with 15 analysts suggesting a “Strong Buy.”
On Apr. 22, Mizuho Financial Group, Inc. (MFG) analyst Brett Linzey kept an “Outperform” rating on EMR and lowered the price target to $135, implying a potential upside of 24.6% from current levels.
The mean price target of $130.08 represents a 20% premium to EMR’s current price levels. The Street-high price target of $160 suggests an ambitious upside potential of 47.6%.
On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

What Are Wall Street Analysts' Target Price for Emerson Electric Stock?

Foster City, California-based Gilead Sciences, Inc. (GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need. Valued at a market cap of $129.1 billion, the company is renowned for its antiviral therapies, particularly in the treatment of HIV/AIDS, hepatitis B and C, and COVID-19, and is advancing treatments in oncology, inflammatory and respiratory diseases.
This healthcare giant has considerably outpaced the broader market over the past 52 weeks. Shares of GILD have rallied 58.7% over this time frame, while the broader S&P 500 Index ($SPX) has gained 12.3%. Moreover, on a YTD basis, the stock is up 12.2%, compared to SPX’s 3.3% decline.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
Zooming in further, GILD’s outperformance looks pronounced when compared to the Invesco Pharmaceuticals ETF’s (PJP) 4.2% rise over the past 52 weeks and marginal downtick on a YTD basis.
On Apr. 24, GILD released weaker-than-expected Q1 earnings results, prompting its share price to plunge 2.8% in the following trading session. The company’s revenue declined marginally year-over-year to $6.7 billion and fell short of the forecasted figure by 2.5%. This decline was mainly due to lower product sales, driven by reduced revenue from its COVID-19 treatment Veklury and weaker Oncology segment performance.
On the earnings front, its adjusted EPS of $1.81 improved significantly from an adjusted loss of $1.32 per share recorded in the same quarter last year, largely due to prior year IPR&D expenses related to the CymaBay acquisition. However, it still came in slightly below the consensus estimates. Adding to the downtick, the company lowered its full-year 2025 EPS guidance, though it maintained its product sales outlook between $28.2 billion and $28.6 billion, with adjusted EPS projected to fall within the $7.70 to $8.10 range.
For the current fiscal year, ending in December, analysts expect GILD’s EPS to grow 71.2% year over year to $7.91. The company’s earnings surprise history is mixed. It exceeded the consensus estimates in three of the last four quarters, while missing on another occasion.
Among the 28 analysts covering the stock, the consensus rating is a “Moderate Buy” which is based on 19 “Strong Buy,” and nine “Hold” ratings.
This configuration is slightly more bullish than a month ago, with 18 analysts suggesting a “Strong Buy” rating.
On May 2, Salim Syed from Mizuho Financial Group, Inc. (MFG) maintained a “Buy” rating on GILD with a price target of $117, which indicates a 12.8% potential upside from the current levels.
The mean price target of $111.88 represents a 7.9% premium from GILD’s current price levels, while the Street-high price target of $140 suggests an upside potential of 35%.
On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Mizuho Financial Group, Inc. Sponosred

Options Strategies